Trial Profile
A Randomized, Positive Controlled Trial That Assess the Safety And Efficacy of Umbilical Cord-Derived Mesenchymal Stem Cells in Moderate and Severe Plaque Psoriasis Patients
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Umbilical cord-Mesenchymal Stem Cell therapy-Tianjin Ever Union Biotechnology (Primary) ; Methotrexate
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Tianjin Ever Union Biotechnology
- 18 Apr 2018 Planned initiation date changed from 1 Apr 2018 to 1 Jun 2018.
- 12 Feb 2018 New trial record